News 2020
Medigus to Enter Online Brands Marketing on Amazon Marketplace
Medigus Signs a non-binding letter of intent to acquire a controlling interest of two companies which operate as sellers of three brands on Amazon Marketplace
Medigus: ScoutCam Announced Acceptance of $2.4M Quote from a Fortune 500 Multinational Healthcare Corporation
Following Acceptance of $2.4M Quote, Preeminent Visual Solutions Creator will Develop Customized Products for Medical Supplies Giant
Medigus to Resell Polyrizon’s Future Products for Protection Against COVID-19 Spread and Other Biological Threats
The companies signed investment and reseller agreements for joint commercialization
GERD IP, A Subsidiary of Medigus, Files Complaint with Delaware District Court Alleging Infringement of two Proprietary Patents
Medigus Increases Holdings in ScoutCam
The Company Increased its Ownership in ScoutCam to 50.1% Following the Conversion of Credit into Equity
Medigus: ScoutCam Granted Canadian Patent for New Endoscope Irrigation Technology
ScoutCam’s Healthcare Technology Further Showcases Company’s Environmentally Resistant & Durable Cameras
Medigus Ltd. Announces Closing of $5 Million Public Offering
Medigus: ScoutCam Achieved Breakthrough with Healthcare’s First of its kind OR-Ready Wireless Endoscope
Medigus Ltd. Announces Pricing of $5 Million Public Offering
Medigus (MDGS) Subsidiary ScoutCam receives $2 million investment from Mori Arkin
Medigus Announces Proposed Public Offering
Medigus Signed an Exclusive Agreement with Elbit Systems Land for the Distribution in Mexico of Pandemic Response Ventilators for COVID-19 Patients
Polyrizon Filed a US Patent Application for Formulations and Methods for Preventing Viral Infections by COVID-19 Virus
Medigus Signs a Collaboration Agreement with L1 Systems for the Commercialization of COVID-19 Medical Products and Solutions
ScoutCam Receives a $500,000 Purchase Order for its Micro Cameras from a Fortune 500 Multinational Healthcare Corporation
Medigus Signed a Binding Letter of Intent with Polyrizon for an Investment in and Joint Commercialization of Biological Gels for Protecting Patients against COVID-19 and Other Biological Threats
Medigus Ltd. Announces 2019 Financial Results
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
